These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26846349)

  • 21. Kinesin Family Member C1 (KIFC1/HSET) Underlies Aggressive Disease in Androgen Receptor-Low and Basal-Like Triple-Negative Breast Cancers.
    Jinna N; Yuan YC; Rida P
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational benchmarking of putative KIFC1 inhibitors.
    Sharma N; Setiawan D; Hamelberg D; Narayan R; Aneja R
    Med Res Rev; 2023 Mar; 43(2):293-318. PubMed ID: 36104980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.
    Xiao KH; Teng K; Ye YL; Tan L; Chen MK; Liang HT; Feng ZH; Duan JL; Deng MH; Wei WS; Luo JH; Qin ZK; Xie D
    Cancer Sci; 2019 Sep; 110(9):2822-2833. PubMed ID: 31278883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer.
    Sekino Y; Oue N; Shigematsu Y; Ishikawa A; Sakamoto N; Sentani K; Teishima J; Matsubara A; Yasui W
    Urol Oncol; 2017 Jan; 35(1):31.e13-31.e20. PubMed ID: 27665358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinesin Family Member C1 (KIFC1/HSET): A Potential Actionable Biomarker of Early Stage Breast Tumorigenesis and Progression of High-Risk Lesions.
    Wright N; Gong Z; Kittles R; Natarajan R; Jovanovic-Talisman T; Rida P; LaBarge M; Seewaldt V
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.
    Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R
    J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of E-cadherin provides tolerance to centrosome amplification in epithelial cancer cells.
    Rhys AD; Monteiro P; Smith C; Vaghela M; Arnandis T; Kato T; Leitinger B; Sahai E; McAinsh A; Charras G; Godinho SA
    J Cell Biol; 2018 Jan; 217(1):195-209. PubMed ID: 29133484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of novel spiro 1,3,4-thiadiazolines as potent, orally bioavailable and brain penetrant KSP inhibitors.
    Mansoor UF; Angeles AR; Dai C; Yang L; Vitharana D; Basso AD; Gray K; Tang H; Liu M; Liang L; Allbritton O; Siddiqui MA
    Bioorg Med Chem; 2015 May; 23(10):2424-34. PubMed ID: 25868746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the kinesin spindle protein: basic principles and clinical implications.
    Sarli V; Giannis A
    Clin Cancer Res; 2008 Dec; 14(23):7583-7. PubMed ID: 19047082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma.
    Fu X; Zhu Y; Zheng B; Zou Y; Wang C; Wu P; Wang J; Chen H; Du P; Liang B; Fang L
    Int J Oncol; 2018 Jun; 52(6):1912-1922. PubMed ID: 29620256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acentrosomal spindle organization renders cancer cells dependent on the kinesin HSET.
    Kleylein-Sohn J; Pöllinger B; Ohmer M; Hofmann F; Nigg EA; Hemmings BA; Wartmann M
    J Cell Sci; 2012 Nov; 125(Pt 22):5391-402. PubMed ID: 22946058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of allosteric inhibitors of kinesin spindle protein (KSP) for the treatment of taxane-refractory cancer: MK-0731 and analogs.
    Cox CD; Garbaccio RM
    Anticancer Agents Med Chem; 2010 Nov; 10(9):697-712. PubMed ID: 21235439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of potent KIFC1 inhibitors using a method of integrated high-throughput synthesis and screening.
    Yang B; Lamb ML; Zhang T; Hennessy EJ; Grewal G; Sha L; Zambrowski M; Block MH; Dowling JE; Su N; Wu J; Deegan T; Mikule K; Wang W; Kaspera R; Chuaqui C; Chen H
    J Med Chem; 2014 Dec; 57(23):9958-70. PubMed ID: 25458601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minus end-directed kinesin-14 KIFC1 regulates the positioning and architecture of the Golgi apparatus.
    She ZY; Pan MY; Tan FQ; Yang WX
    Oncotarget; 2017 May; 8(22):36469-36483. PubMed ID: 28430595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High KIFC1 expression is associated with poor prognosis in prostate cancer.
    Kostecka LG; Olseen A; Kang K; Torga G; Pienta KJ; Amend SR
    Med Oncol; 2021 Mar; 38(5):47. PubMed ID: 33760984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KIFC1 regulates ZWINT to promote tumor progression and spheroid formation in colorectal cancer.
    Akabane S; Oue N; Sekino Y; Asai R; Thang PQ; Taniyama D; Sentani K; Yukawa M; Toda T; Kimura KI; Egi H; Shimizu W; Ohdan H; Yasui W
    Pathol Int; 2021 Jul; 71(7):441-452. PubMed ID: 33819373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phenanthrene derived PARP inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cells.
    Castiel A; Visochek L; Mittelman L; Dantzer F; Izraeli S; Cohen-Armon M
    BMC Cancer; 2011 Sep; 11():412. PubMed ID: 21943092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth arrest and apoptosis induced by kinesin Eg5 inhibitor K858 and by its 1,3,4-thiadiazoline analogue in tumor cells.
    Giantulli S; De Iuliis F; Taglieri L; Carradori S; Menichelli G; Morrone S; Scarpa S; Silvestri I
    Anticancer Drugs; 2018 Aug; 29(7):674-681. PubMed ID: 29738338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ATM and ATR kinases regulate centrosome clustering and tumor recurrence by targeting KIFC1 phosphorylation.
    Fan G; Sun L; Meng L; Hu C; Wang X; Shi Z; Hu C; Han Y; Yang Q; Cao L; Zhang X; Zhang Y; Song X; Xia S; He B; Zhang S; Wang C
    Nat Commun; 2021 Jan; 12(1):20. PubMed ID: 33397932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KIFC1 is essential for acrosome formation and nuclear shaping during spermiogenesis in the lobster Procambarus clarkii.
    Ma DD; Bi L; Yang WX
    Oncotarget; 2017 May; 8(22):36082-36098. PubMed ID: 28415605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.